ArticleAmerican journal of translational research2018

Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model.

Kun Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.